Mr. Speaker, I yield myself 5 minutes. Mr. Speaker, it has been nearly 2 years since the House of Representatives passed the Stem Cell Research Enhancement Act in an attempt to lift the crippling ban on lifesaving research. During those 2…
Mr. Speaker, I yield myself 5 minutes.
Mr. Speaker, it has been nearly 2 years since the House of Representatives passed the Stem Cell Research Enhancement Act in an attempt to lift the crippling ban on lifesaving research. During those 2 years, a lot has happened. The Senate overwhelmingly passed the bill, President Bush issued the first veto of his 6-year Presidency to kill it, new elections were held, and a rash of new pro-research Members won, in many cases defeating incumbents who oppose this research.
Public support has surged for stem cells. Over 71 percent of the public now supports this research, a stunning 20 percent increase since the vote in 2005.
There are other developments that have happened in the last 2 years. Great progress in research is being conducted overseas, out of the hands and out of the oversight of our distinguished scientists here at home. Stem cell research is proceeding unfettered and, in some cases, without ethical standards in other countries. And even when these countries have ethical standards, our failures are allowing them to gain the scientific edge over the U.S.
In Japan, scientists have used embryonic stem cell therapies to reduce hepatic failure in mice. In the U.K., the government has now committed to spending $1.3 billion on stem cell research in the next 10 years. Singapore is spending $7.5 billion on biomedical research over the next 5 years and is actively courting American stem cell researchers.
The first embryonic stem cell line may have been created in the United States, but the majority of new lines are being created overseas. We were once on the cutting edge of this groundbreaking research, but we have now effectively handed over the reins to those outside our borders while our own researchers remain tethered by a restrictive 6-year-old policy and we still have no Federal ethical standards over this research.
But there is one thing that has not changed since we last considered this bill. Millions of people in this country and around the world are still stricken by disease, accidents are still leaving people paralyzed, too many people are becoming victims of Alzheimer's, Parkinson's, heart disease, sickle cell anemia, diabetes, and many other debilitating diseases. Cancer hasn't been cured.
Some suggest that it is Congress' role to tell researchers what kinds of cells to use, adult stem cells, cord blood, so-called ANT, amniotic, and others. I suggest we are not the arbiters of research. Instead, we should foster all of these methods, and we should
adequately fund and have ethical oversight over all ethical stem cell research. Embryonic stem cell research has shown the most promise of almost any current research today for potentially curing these and hundreds of other diseases and injuries.
The distinguished minority leader is wrong when he says amniotic stem cells are a substitute for embryonic stem cells. The researcher at Wake Forest University in fact says specifically that these cells are not a substitute, and we need to have both types of research, as well as all of the other kinds to have the maximum potential to cure disease.
The minority leader said we need to foster the kind of research that has the most promise. And there is the one place we will agree today, because the most promise, all researchers agree, is held by embryonic stem cell research.
Well, here we are again, and here we are going to come time after time until this bill passes. This bill will become law, and we will not tire in our efforts until it does for the millions of Americans who suffer from diseases.
Mr. President, today, we want to give you another chance to do the right thing. Today, the House will vote to give hope to millions of Americans. I urge my colleagues to vote for life, to vote for hope, to vote ``yes'' on H.R. 3.
Mr. Speaker, I reserve the balance of my time.
Announcement by the Speaker Pro Tempore
Mr. Speaker, I am honored now to yield to the distinguished gentleman from Rhode Island (Mr. Langevin) 3 minutes.
(Mr. LANGEVIN asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am delighted to yield now 2 minutes to the distinguished new Member from Tennessee (Mr. Cohen).
Mr. Speaker, I am delighted to yield 2 minutes to the distinguished new Member from Pennsylvania (Mr. Altmire) for his maiden floor speech.
Mr. Speaker, I yield myself 2 minutes.
Mr. Speaker, we have heard from several speakers on the other side that allegedly adult stem cells have cured a myriad of diseases. Apparently, the scorecard is now up to 72. In fact, as the researchers have shown, Dr. Shane Smith, William Neaves and Steven Teitelbaum, the opponents say that a myriad of diseases have been cured by adult stem cells, but, in fact, adult stem cell treatments fully tested, fully tested in all required phases of clinical trials, have cured nine conditions, not 65 or 72; and all of those conditions were blood- related conditions.
They were not the kinds of conditions that embryonic stem cells have shown promise for and have shown hope for. Embryonic stem cells have only been around for about 8 years, and the President's restrictions have greatly hampered research; but, nonetheless, these cells show great promise.
The researchers conclude: ``By promoting the falsehood that adult stem cell treatments are already in general use for 65 or more diseases and injuries, Prentice and those who repeat his claims mislead lay people and cruelly deceive patients.''
Mr. Speaker, I yield 2 minutes to the distinguished gentleman from Colorado (Mr. Perlmutter).
Mr. Speaker, I yield 1 minute to the distinguished gentlewoman from Missouri (Mrs. Emerson).
Mr. Speaker, I am now pleased to yield 2 minutes to the distinguished new Member from Ohio (Mr. Space).
Mr. Speaker, I yield myself 1 minute.
Mr. Speaker, the previous speaker alleged that Dr. Atala, who is doing the embryonic stem cell research, said that it is not the way to go, that embryonic stem cell research is not the way to go.
In fact, in the letter that my distinguished colleague Mr. Castle has already submit for the record, Dr. Atala specifically says that amniotic stem cell research is not a substitute for embryonic research. And he further says: It is essential that National Institutes of Health funded researchers are able to fully pursue embryonic stem cell research as a complement to research into other forms of stem cells.
Mr. Speaker, I am very pleased to yield 2 minutes to the distinguished new member from Connecticut (Mr. Murphy).
Mr. Speaker, I am now delighted to yield 2 minutes to another new Member, the distinguished gentleman from Pennsylvania (Mr. Patrick J. Murphy).
Mr. Speaker, I would be delighted to yield 1 minute to the gentleman from Pennsylvania (Mr. Dent).
(Mr. DENT asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am delighted to yield 2 minutes to the distinguished new Member from Florida (Mr. Klein).
Mr. Speaker, I am very pleased to yield 2 minutes to the distinguished new Member from Pennsylvania (Mr. Sestak).
Mr. Speaker, I am pleased to now yield 1 minute to the distinguished majority leader, Mr. Hoyer.
Mr. Speaker, I am pleased to yield 2 minutes to the distinguished gentleman from Arizona (Mr. Mitchell).
Mr. Speaker, I yield myself 1 minute.
Mr. Speaker, the gentleman from Indiana and several other people have said they don't think taxpayers should fund this research. But, in fact, we have a national consensus in this country in support of taxpayer funding for embryonic stem cell research, 72 percent, to be exact. We fund all other types of this research, so we have this national consensus.
My constituents in the First Congressional District of Colorado, the vast majority, the majority, do not want to fund this war. That doesn't mean, Mr. Speaker, that they don't have to pay their taxpayer dollars.
We should fund this with taxpayer dollars because the NIH and our public institutions are the driving force behind basic research for the private researchers, for the foreign researchers and for all of this wonderful research that is going to, we hope, cure diseases.
Mr. Speaker, I am delighted to yield 2 minutes to the distinguished new Member from Illinois (Mr. Hare).
Mr. Speaker, I am delighted now to yield 1 minute to the distinguished new Member from New York (Mr. Hall).
(Mr. HALL of New York asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am delighted to yield now to the gentleman and new Member from Kentucky (Mr. Yarmuth) 1 minute.
(Mr. YARMUTH asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am now pleased to yield to the distinguished gentlewoman from the Energy and Commerce Committee, my colleague, Ms. Eshoo, 2 minutes.
Mr. Speaker, I am now very pleased to recognize my friend and colleague from Michigan (Mr. Stupak) for 3 minutes.
(Mr. STUPAK asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I yield 3 minutes to the distinguished Member from Missouri (Mr. Cleaver).
Mr. Speaker, I yield 2\1/2\ minutes to the gentlewoman from New York (Ms. Slaughter), the chairwoman of the Rules Committee.
Mr. Speaker, I yield 2 minutes to the distinguished gentleman from Texas (Mr. Gene Green), a member of the Energy and Commerce Committee.
Mr. Speaker, I yield 2 minutes to the distinguished gentlewoman from Illinois (Ms. Schakowsky).
Mr. Speaker, I yield 2 minutes to the distinguished gentleman from Maine (Mr. Allen).
Mr. Speaker, I yield myself 30 seconds.
Mr. Speaker, my colleague from Georgia holds up a picture of two beautiful little girls and says we would not want to destroy them for research. He absolutely has that right. In fact, Mr. Speaker, I take deep offense at any insinuation that we would kill children for this type of research.
The thing to know, H.R. 3 specifically says the only embryos we will allow for this research is embryos created for IVF clinics which are slated to be thrown away, embryos which are never implanted and will never become babies.
Mr. Speaker, I yield 2 minutes to my distinguished colleague from Massachusetts (Mr. Markey).
Mr. Speaker, I yield 2 minutes to the distinguished gentleman from New York (Mr. Crowley).
Mr. Speaker, I yield 1\1/2\ minutes to the gentleman from Texas (Mr. Doggett).
Mr. Speaker, I am pleased to yield 2\1/2\ minutes to the distinguished gentlewoman from California, a member of the committee, Mrs. Capps.
No. The gentleman can use his own time.
No. He can use his own time.
Mr. Speaker, I am pleased to yield 2 minutes to the distinguished gentleman from Missouri (Mr. Carnahan).
Mr. Speaker, I am pleased to yield now 2 minutes to the gentlewoman from California (Ms. Solis).
Mr. Speaker, I am pleased to yield 2 minutes to the distinguished gentlewoman from Ohio, Mrs. Tubbs Jones.
(Mrs. JONES of Ohio asked and was given permission to revise and extend her remarks.)
Mr. Speaker, I am pleased now to yield 2\1/2\ minutes to the gentleman from New York (Mr. Engel), a member of the committee.
Mr. Speaker, I am pleased now to yield 2 minutes to the distinguished new Member from Wisconsin, Dr. Kagen.
Mr. Speaker, I am now very pleased to yield 2 minutes to the gentlewoman from Pennsylvania (Ms. Schwartz).
Mr. Speaker, I yield 2 minutes to the distinguished gentleman from New Jersey (Mr. Pallone).
Mr. Speaker, I am pleased to now yield 2 minutes to the distinguished gentleman from Illinois (Mr. Lipinski).
Mr. Speaker, I am pleased to yield 1 minute to the distinguish gentleman from Oregon (Mr. Blumenauer).
Mr. Speaker, I would inquire as to the time remaining on each side.
Mr. Speaker, I now recognize the gentleman from New Jersey (Mr. Pascrell) for 1 minute.
Mr. Speaker, I yield 1 minute to the gentlelady from Texas (Ms. Jackson-Lee).
(Ms. JACKSON-LEE of Texas asked and was given permission to revise and extend her remarks.)
Announcement by the Speaker Pro Tempore
Mr. Speaker, I am pleased to yield 1 minute to the distinguished gentleman from Illinois (Mr. Davis).
(Mr. DAVIS of Illinois asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am pleased to yield 1 minute to the gentleman from Wisconsin (Mr. Kind).
(Mr. KIND asked and was given permission to revise and extend his remarks.)
Mr. Speaker, I am pleased to yield 2 minutes to the distinguished Democratic Caucus Chair, the gentleman from Illinois (Mr. Emanuel).
Mr. Speaker, I do not know if now would be the time to yield 2 of my last minutes also to Mr. Barton.
Mr. Speaker, I yield myself the remaining time.
Mr. Speaker, I want to thank Ranking Member Barton for his thoughtful, thoughtful approach and his support of this issue. I also want to thank my friend and compadre, Mr. Castle, who has fought hand in hand for this legislation with me for years now. And I also want to thank the many Members who have helped us through this long process and will be helping us long after today.
This is the first time I can remember a bipartisan whip effort in the 10 years I have been in Congress. Ms. Baldwin, Mrs. Bono, Mr. Bradley, Mrs. Capps, Mr. Carnahan, Mr. Dent, Mr. Kirk, Mr. Langevin, Mr. Perlmutter, and Mr. Upton. Thank you, thank you, and our work is not completed.
I want to talk for a minute about what H.R. 3 does, because there are a lot of misstatements that have been made today on this floor. H.R. 3 simply expands the number of stem cell lines that can be used for research that is done in an ethical manner.
In 2001, President Bush restricted stem cell research to lines that existed as of that date. In the ensuing years, we have learned there were not 73 lines, as has been asserted today, but somewhere between 19 and 22 lines. We learned that all of those lines are contaminated with mouse feeder cells and are not appropriate for clinical use. We learned that the research is going offshore and into private hands. Perhaps most disturbingly, we learned that the U.S. Government has no ethical control over current private research or State research into embryonic stem cell lines.
For that reason, we drafted a bill that both expands the research and sets forward a rigid code of ethics. Only cells that are created to give life for in vitro fertilization but then are slated to be thrown away as medical waste, thrown away, can be donated for this research, by informed consent. It is very narrow and it is very ethical. That is why 522 patient advocacy groups, health organizations, research universities, scientific societies, religious groups, and other associations have endorsed this bill. It expands research, and it does it in an ethical way.
Embryonic stem cells were first identified from mouse embryos in 1981 and primate embryos in 1995; but until November 1998, animal embryos were the only source for research. In 1998, for the first time, researchers learned that embryonic stem cells could be used in humans, and that is when we found so much potential, potential for diseases that affect 110 million Americans and their families, Americans suffering from diabetes, Parkinson's, nerve damage, and on and on.
The great promise of this research is why people like Nancy Reagan, Michael J. Fox, Orrin Hatch, Mary Tyler Moore, pro-life and pro-choice, have come together to say, we cannot deny this research. We must not say let's just throw these cells away and discard them. Let's allow people to donate them in order to give life and to give hope.
Now, the opposition tries to obfuscate this issue time and time again, and we simply cannot let that happen. We are not researchers; we are Congress. It is our job to promote all ethical scientific research, not to pick and choose among methods. I can't think of a time when Congress says, oh, scientists, use that method to research cancer cures but not this method. That is not our job. Our job is to say let's support all ethical research, adult stem cells, cord blood, alternative methods, amniotic stem cells, and embryonic stem cell research.
In conclusion, I will say that this is the next step on a long road; and I implore all of you to think not about yourself, not even about your parents, but your grandchildren and your great grandchildren. When we find these cures, we will say we did the right thing today. Vote ``yes'' on H.R. 3.
Mr. Speaker, I rise in opposition to motion to recommit.
Mr. Speaker, this motion does not ban human cloning. It does not ban reproductive cloning. What it is, is a desperate attempt to derail ethical scientific research on embryonic stem cell research, which is unrelated.
Not a single person in this House supports reproductive cloning. But again, the motion doesn't ban reproductive cloning. What it does is it says, if you are an entity conducting research on Somatic Cell Nuclear Transfer, which is a way to look at these cells, with private dollars, not even with public dollars, you will be prevented from receiving Federal funding for conducting embryonic stem cell research. This will, frankly, tie the hands of some of the preeminent research entities in the world from conducting this life-saving research.
The motion is a thinly veiled attempt to define human life in a manner that can have profound implications beyond the issues raised in H.R. 3. It contains vague terms like ``assurances'' and undefined terms such as ``satisfaction of the Secretary.''
What the frank intent of this motion is, is to gut H.R. 3 by strapping it with undefined standards and terms that are extraneous to the bill. The motion is a procedural vote without meaning. It is a ruse, a red herring designed to frighten, to obfuscate and to distract.
We all think that banning reproductive cloning is important, and that is
why the chairman of the Energy and Commerce Committee has assured me that he will examine this issue further to see what legislation we can do to protect ourselves.
And I will finally say, I do not know of one research institution which would be eligible for Federal funds through the NIH under H.R. 3 that is conducting any experiments or attempts for human reproductive cloning; it is unethical, and our research institutions are not engaged in these efforts.
Rather than a sincere attempt to legislate on matters of great importance, this motion is partisan, and it should be defeated.
With that, Mr. Speaker, I plan to vote ``no'' on this motion, I strongly encourage my colleagues to vote ``no.''
And I yield the balance of my time to the distinguished gentleman from Delaware (Mr. Castle).
Mr. Speaker, I yield back the balance of my time.